Professor Riboli has made an exceptional impact on the fields of epidemiology, cancer prevention and the fight against chronic illness. Before coming to Imperial, he worked at the International Agency for Research on Cancer of W.H.O. where he initiated ground-breaking research on the role of diet, nutrition and metabolic health in cancer causation and prevention. He designed and led the establishment of the largest international population cohort studies on nutrition and cancer, the European Prospective Investigation into Cancer and Nutrition (EPIC) that recruited over half-a-million participants with rich phenotyping data and blood samples stored in the first dedicated large-scale population biobank. After moving to Imperial College he continued to lead research on modifiable, lifestyle related, cancer risk factors, including metabolic syndrome components and inflammation. In recognition of his achievements in cancer epidemiology and public health Professor Riboli has been elected as an Honorary Fellow of the Faculty of Public Health of the Royal College of Physicians and a Fellow of the Academy of Medical Sciences.